Catalyst Wire Dossier Catalyst Wire Dossier

Natalizumab (Tysabri)

Natalizumab · Biogen
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Natalizumab (Tysabri), covering 2015-07-29 to 2016-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Alternative Treatment Paradigm for Natalizumab Trial [Phase 2]

See pricing